Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 13 | 2024 | 3251 | 2.030 |
Why?
|
Cardiovascular Diseases | 38 | 2024 | 15651 | 1.910 |
Why?
|
Coronary Disease | 11 | 2018 | 5912 | 1.670 |
Why?
|
Cholesterol | 12 | 2024 | 2898 | 1.480 |
Why?
|
Primary Prevention | 7 | 2024 | 1187 | 1.270 |
Why?
|
Hypertension | 16 | 2024 | 8626 | 1.270 |
Why?
|
Body Mass Index | 22 | 2024 | 13039 | 1.240 |
Why?
|
Overweight | 11 | 2024 | 2443 | 1.190 |
Why?
|
Blood Pressure | 15 | 2022 | 8532 | 1.030 |
Why?
|
Diet | 14 | 2020 | 8086 | 1.030 |
Why?
|
Life Style | 7 | 2020 | 3926 | 0.990 |
Why?
|
Models, Statistical | 11 | 2020 | 5089 | 0.910 |
Why?
|
Stroke | 10 | 2024 | 9747 | 0.860 |
Why?
|
Diabetes Mellitus, Type 2 | 13 | 2024 | 12240 | 0.850 |
Why?
|
Growth Disorders | 8 | 2021 | 633 | 0.790 |
Why?
|
Iran | 7 | 2024 | 761 | 0.700 |
Why?
|
Developing Countries | 14 | 2021 | 2911 | 0.690 |
Why?
|
Risk Factors | 59 | 2024 | 74836 | 0.670 |
Why?
|
Diabetes Mellitus | 13 | 2022 | 5891 | 0.650 |
Why?
|
Economics | 2 | 2019 | 141 | 0.640 |
Why?
|
History of Medicine | 1 | 2019 | 42 | 0.630 |
Why?
|
Internationality | 3 | 2021 | 1007 | 0.620 |
Why?
|
Tobacco Smoke Pollution | 1 | 2024 | 827 | 0.610 |
Why?
|
Obesity | 13 | 2024 | 13075 | 0.600 |
Why?
|
Tanzania | 10 | 2024 | 1407 | 0.600 |
Why?
|
Antihypertensive Agents | 4 | 2019 | 2033 | 0.590 |
Why?
|
Aspirin | 2 | 2024 | 3134 | 0.570 |
Why?
|
Mortality | 10 | 2022 | 2904 | 0.570 |
Why?
|
Risk Assessment | 19 | 2024 | 24283 | 0.550 |
Why?
|
Chest Pain | 1 | 2024 | 1100 | 0.550 |
Why?
|
Poverty Areas | 3 | 2024 | 268 | 0.550 |
Why?
|
Diet Records | 1 | 2018 | 425 | 0.530 |
Why?
|
Blood Glucose | 7 | 2015 | 6425 | 0.530 |
Why?
|
Risk Reduction Behavior | 2 | 2020 | 1123 | 0.530 |
Why?
|
Cholesterol, LDL | 4 | 2024 | 2393 | 0.520 |
Why?
|
Humans | 145 | 2024 | 765956 | 0.510 |
Why?
|
Female | 103 | 2024 | 396101 | 0.500 |
Why?
|
Vulnerable Populations | 2 | 2021 | 718 | 0.500 |
Why?
|
Practice Guidelines as Topic | 3 | 2024 | 7425 | 0.480 |
Why?
|
Insurance, Health | 4 | 2021 | 2520 | 0.480 |
Why?
|
Cooking | 1 | 2017 | 327 | 0.470 |
Why?
|
Apolipoproteins | 1 | 2017 | 327 | 0.460 |
Why?
|
Adult | 70 | 2024 | 223038 | 0.460 |
Why?
|
Male | 90 | 2024 | 363691 | 0.460 |
Why?
|
Middle Aged | 62 | 2024 | 223004 | 0.450 |
Why?
|
Diet Surveys | 1 | 2018 | 1159 | 0.450 |
Why?
|
C-Reactive Protein | 2 | 2017 | 3850 | 0.440 |
Why?
|
Aged | 50 | 2024 | 171114 | 0.440 |
Why?
|
Kenya | 3 | 2021 | 758 | 0.440 |
Why?
|
Dental Health Services | 1 | 2013 | 48 | 0.430 |
Why?
|
Electronic Health Records | 3 | 2023 | 4873 | 0.430 |
Why?
|
Food Preferences | 1 | 2017 | 397 | 0.420 |
Why?
|
Prevalence | 21 | 2023 | 15839 | 0.420 |
Why?
|
Myocardial Infarction | 3 | 2024 | 11501 | 0.420 |
Why?
|
Waist-Hip Ratio | 1 | 2014 | 520 | 0.420 |
Why?
|
Smoking Cessation | 4 | 2024 | 2084 | 0.410 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2024 | 2770 | 0.410 |
Why?
|
Comparative Effectiveness Research | 3 | 2022 | 714 | 0.410 |
Why?
|
Feeding Behavior | 6 | 2020 | 3211 | 0.410 |
Why?
|
Weight Loss | 2 | 2016 | 2710 | 0.410 |
Why?
|
Urbanization | 1 | 2013 | 101 | 0.400 |
Why?
|
Selection Bias | 3 | 2019 | 361 | 0.400 |
Why?
|
Life Expectancy | 4 | 2019 | 1247 | 0.390 |
Why?
|
Public Health | 3 | 2020 | 2680 | 0.390 |
Why?
|
Health Surveys | 8 | 2016 | 4056 | 0.390 |
Why?
|
Exercise | 8 | 2020 | 5937 | 0.390 |
Why?
|
Cause of Death | 7 | 2024 | 3708 | 0.380 |
Why?
|
Population Surveillance | 2 | 2016 | 2590 | 0.380 |
Why?
|
HIV Infections | 9 | 2024 | 17533 | 0.380 |
Why?
|
Quality-Adjusted Life Years | 7 | 2020 | 1737 | 0.380 |
Why?
|
Fibrinogen | 1 | 2015 | 895 | 0.370 |
Why?
|
Obesity, Abdominal | 1 | 2014 | 370 | 0.370 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 2 | 2023 | 160 | 0.360 |
Why?
|
Malnutrition | 4 | 2021 | 629 | 0.350 |
Why?
|
Child Development | 6 | 2019 | 2327 | 0.350 |
Why?
|
Waist Circumference | 1 | 2014 | 933 | 0.350 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2024 | 10383 | 0.340 |
Why?
|
Energy Intake | 1 | 2018 | 2140 | 0.340 |
Why?
|
Health Personnel | 2 | 2021 | 3390 | 0.340 |
Why?
|
Developed Countries | 5 | 2017 | 452 | 0.340 |
Why?
|
Observation | 1 | 2012 | 309 | 0.340 |
Why?
|
Hypercholesterolemia | 3 | 2015 | 1149 | 0.330 |
Why?
|
Wounds and Injuries | 6 | 2020 | 2511 | 0.330 |
Why?
|
Geography | 2 | 2018 | 652 | 0.320 |
Why?
|
Myocardial Ischemia | 2 | 2012 | 2128 | 0.320 |
Why?
|
Thinness | 4 | 2023 | 482 | 0.300 |
Why?
|
Alcohol Drinking | 3 | 2023 | 4040 | 0.300 |
Why?
|
Smoking | 7 | 2023 | 9081 | 0.300 |
Why?
|
Oral Health | 1 | 2013 | 493 | 0.300 |
Why?
|
Age Factors | 12 | 2024 | 18380 | 0.290 |
Why?
|
Healthcare Disparities | 2 | 2016 | 3412 | 0.290 |
Why?
|
Cross-Sectional Studies | 14 | 2023 | 26313 | 0.280 |
Why?
|
Health Services Accessibility | 3 | 2021 | 5506 | 0.280 |
Why?
|
Health Resources | 1 | 2013 | 949 | 0.280 |
Why?
|
Health Transition | 2 | 2019 | 35 | 0.280 |
Why?
|
International Cooperation | 1 | 2013 | 1432 | 0.270 |
Why?
|
Sex Factors | 9 | 2024 | 10602 | 0.270 |
Why?
|
Age Distribution | 7 | 2018 | 2858 | 0.270 |
Why?
|
Weight Gain | 4 | 2024 | 2355 | 0.270 |
Why?
|
England | 2 | 2018 | 533 | 0.260 |
Why?
|
Virus Diseases | 1 | 2012 | 718 | 0.260 |
Why?
|
Cost of Illness | 5 | 2017 | 1950 | 0.260 |
Why?
|
Uganda | 3 | 2020 | 1353 | 0.260 |
Why?
|
India | 5 | 2024 | 2334 | 0.260 |
Why?
|
Self-Help Groups | 2 | 2024 | 193 | 0.250 |
Why?
|
Latin America | 4 | 2020 | 416 | 0.250 |
Why?
|
Nutrition Surveys | 4 | 2016 | 1741 | 0.250 |
Why?
|
Preventive Health Services | 1 | 2010 | 570 | 0.240 |
Why?
|
Food Supply | 3 | 2021 | 544 | 0.240 |
Why?
|
Bayes Theorem | 8 | 2023 | 2354 | 0.240 |
Why?
|
Motor Skills | 2 | 2019 | 516 | 0.230 |
Why?
|
Aged, 80 and over | 20 | 2024 | 59488 | 0.230 |
Why?
|
Income | 6 | 2021 | 1874 | 0.230 |
Why?
|
Prospective Studies | 16 | 2024 | 54806 | 0.230 |
Why?
|
Primary Health Care | 1 | 2021 | 4736 | 0.230 |
Why?
|
Cotinine | 1 | 2024 | 206 | 0.220 |
Why?
|
Bacterial Infections | 1 | 2012 | 1387 | 0.220 |
Why?
|
Sex Distribution | 6 | 2017 | 2263 | 0.220 |
Why?
|
Nigeria | 3 | 2023 | 782 | 0.210 |
Why?
|
Caribbean Region | 2 | 2020 | 193 | 0.210 |
Why?
|
Follow-Up Studies | 10 | 2020 | 39194 | 0.210 |
Why?
|
Self Administration | 1 | 2024 | 385 | 0.210 |
Why?
|
Micronutrients | 2 | 2023 | 390 | 0.200 |
Why?
|
Fibrinolytic Agents | 1 | 2012 | 2080 | 0.200 |
Why?
|
Metabolic Diseases | 1 | 2009 | 687 | 0.200 |
Why?
|
Cognition | 5 | 2019 | 7048 | 0.200 |
Why?
|
Venezuela | 1 | 2022 | 73 | 0.200 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2020 | 953 | 0.190 |
Why?
|
Child Mortality | 2 | 2015 | 204 | 0.190 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 4058 | 0.190 |
Why?
|
Models, Theoretical | 4 | 2021 | 3564 | 0.190 |
Why?
|
South Africa | 3 | 2023 | 1867 | 0.190 |
Why?
|
Cyclonic Storms | 1 | 2023 | 121 | 0.190 |
Why?
|
Program Development | 2 | 2018 | 1295 | 0.190 |
Why?
|
Time Factors | 7 | 2024 | 40065 | 0.190 |
Why?
|
Child, Preschool | 24 | 2020 | 42500 | 0.190 |
Why?
|
Vitamins | 2 | 2023 | 1630 | 0.180 |
Why?
|
Diet, Fat-Restricted | 1 | 2024 | 328 | 0.180 |
Why?
|
Europe | 3 | 2020 | 3423 | 0.180 |
Why?
|
Health Status | 4 | 2017 | 4080 | 0.180 |
Why?
|
Transients and Migrants | 1 | 2023 | 170 | 0.180 |
Why?
|
Africa, Western | 1 | 2020 | 160 | 0.180 |
Why?
|
Argentina | 2 | 2021 | 249 | 0.170 |
Why?
|
Symporters | 1 | 2023 | 362 | 0.170 |
Why?
|
Statistics as Topic | 2 | 2017 | 2352 | 0.170 |
Why?
|
Developmental Disabilities | 2 | 2019 | 1519 | 0.170 |
Why?
|
Dietary Supplements | 4 | 2023 | 3426 | 0.160 |
Why?
|
Persia | 1 | 2019 | 7 | 0.160 |
Why?
|
Cohort Studies | 9 | 2022 | 41647 | 0.160 |
Why?
|
Food Safety | 1 | 2019 | 24 | 0.160 |
Why?
|
South America | 2 | 2017 | 179 | 0.160 |
Why?
|
Socioeconomic Factors | 7 | 2021 | 7836 | 0.160 |
Why?
|
Folic Acid | 2 | 2023 | 1339 | 0.160 |
Why?
|
Norway | 1 | 2020 | 499 | 0.160 |
Why?
|
History, Ancient | 1 | 2019 | 213 | 0.150 |
Why?
|
Infant | 21 | 2020 | 36385 | 0.150 |
Why?
|
United States | 13 | 2024 | 72898 | 0.150 |
Why?
|
Seafood | 1 | 2021 | 395 | 0.150 |
Why?
|
Body Weight | 4 | 2017 | 4622 | 0.150 |
Why?
|
Time | 1 | 2020 | 550 | 0.150 |
Why?
|
Incidence | 8 | 2024 | 21480 | 0.150 |
Why?
|
Trans Fatty Acids | 1 | 2019 | 155 | 0.150 |
Why?
|
Financing, Personal | 1 | 2020 | 310 | 0.150 |
Why?
|
Linear Models | 3 | 2017 | 5876 | 0.140 |
Why?
|
Brazil | 3 | 2020 | 1248 | 0.140 |
Why?
|
Diet, Sodium-Restricted | 1 | 2019 | 291 | 0.140 |
Why?
|
Coronary Artery Disease | 1 | 2017 | 6546 | 0.140 |
Why?
|
Inflammation | 1 | 2017 | 10850 | 0.140 |
Why?
|
Asia | 5 | 2017 | 628 | 0.140 |
Why?
|
Intention to Treat Analysis | 1 | 2018 | 416 | 0.140 |
Why?
|
Food Analysis | 1 | 2017 | 104 | 0.140 |
Why?
|
Growth | 2 | 2016 | 365 | 0.130 |
Why?
|
Treatment Outcome | 8 | 2024 | 65189 | 0.130 |
Why?
|
Infant, Low Birth Weight | 1 | 2021 | 871 | 0.130 |
Why?
|
Neoplasms | 4 | 2024 | 22340 | 0.130 |
Why?
|
Educational Status | 3 | 2023 | 2513 | 0.130 |
Why?
|
Africa South of the Sahara | 4 | 2020 | 751 | 0.130 |
Why?
|
Feasibility Studies | 3 | 2022 | 5302 | 0.130 |
Why?
|
Adiposity | 2 | 2017 | 1890 | 0.130 |
Why?
|
Pregnancy | 11 | 2023 | 30258 | 0.120 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2017 | 292 | 0.120 |
Why?
|
Adolescent | 18 | 2023 | 88832 | 0.120 |
Why?
|
Child, Orphaned | 1 | 2016 | 55 | 0.120 |
Why?
|
Cardiology | 2 | 2024 | 1702 | 0.120 |
Why?
|
Aging | 1 | 2014 | 8731 | 0.120 |
Why?
|
Anti-Retroviral Agents | 3 | 2024 | 1787 | 0.120 |
Why?
|
Physical Education and Training | 1 | 2015 | 102 | 0.120 |
Why?
|
Africa | 3 | 2013 | 725 | 0.120 |
Why?
|
Drug Prescriptions | 1 | 2024 | 1662 | 0.120 |
Why?
|
Vitamin A Deficiency | 1 | 2015 | 88 | 0.120 |
Why?
|
Public Policy | 1 | 2019 | 551 | 0.120 |
Why?
|
Health Status Disparities | 2 | 2017 | 1880 | 0.120 |
Why?
|
Poverty | 5 | 2021 | 2714 | 0.120 |
Why?
|
Spouse Abuse | 1 | 2016 | 181 | 0.120 |
Why?
|
Child Nutrition Disorders | 1 | 2016 | 139 | 0.120 |
Why?
|
Decision Support Techniques | 1 | 2024 | 2003 | 0.110 |
Why?
|
Mass Media | 1 | 2017 | 301 | 0.110 |
Why?
|
Infant, Newborn | 14 | 2021 | 26349 | 0.110 |
Why?
|
Cities | 1 | 2017 | 543 | 0.110 |
Why?
|
Iron | 1 | 2023 | 1816 | 0.110 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2017 | 395 | 0.110 |
Why?
|
Hong Kong | 2 | 2024 | 169 | 0.110 |
Why?
|
Birth Intervals | 1 | 2014 | 54 | 0.110 |
Why?
|
Morbidity | 5 | 2021 | 1749 | 0.110 |
Why?
|
Disease | 2 | 2010 | 676 | 0.110 |
Why?
|
Young Adult | 18 | 2024 | 59886 | 0.110 |
Why?
|
Triglycerides | 2 | 2024 | 2441 | 0.110 |
Why?
|
Body Height | 3 | 2015 | 1562 | 0.110 |
Why?
|
Salaries and Fringe Benefits | 1 | 2016 | 258 | 0.110 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2015 | 153 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2022 | 1240 | 0.110 |
Why?
|
Principal Component Analysis | 1 | 2017 | 951 | 0.110 |
Why?
|
Chronic Disease | 4 | 2023 | 9347 | 0.110 |
Why?
|
Blood Pressure Determination | 1 | 2017 | 647 | 0.110 |
Why?
|
Cost-Benefit Analysis | 2 | 2024 | 5526 | 0.110 |
Why?
|
Western World | 1 | 2013 | 26 | 0.110 |
Why?
|
Proportional Hazards Models | 6 | 2024 | 12509 | 0.110 |
Why?
|
Emigrants and Immigrants | 1 | 2020 | 549 | 0.110 |
Why?
|
Climate Change | 1 | 2020 | 509 | 0.100 |
Why?
|
Middle East | 3 | 2020 | 237 | 0.100 |
Why?
|
Residence Characteristics | 3 | 2019 | 2115 | 0.100 |
Why?
|
Thiazides | 1 | 2012 | 19 | 0.100 |
Why?
|
Politics | 1 | 2019 | 822 | 0.100 |
Why?
|
Vitamin B Complex | 1 | 2014 | 299 | 0.100 |
Why?
|
Calibration | 1 | 2015 | 814 | 0.100 |
Why?
|
Wasting Syndrome | 1 | 2013 | 95 | 0.100 |
Why?
|
Child | 20 | 2021 | 80563 | 0.100 |
Why?
|
Longitudinal Studies | 5 | 2020 | 14749 | 0.100 |
Why?
|
Evidence-Based Medicine | 1 | 2024 | 3685 | 0.100 |
Why?
|
Hemorrhage | 1 | 2024 | 3461 | 0.100 |
Why?
|
Meta-Analysis as Topic | 1 | 2017 | 1370 | 0.100 |
Why?
|
Commerce | 1 | 2017 | 611 | 0.100 |
Why?
|
Uric Acid | 1 | 2018 | 809 | 0.100 |
Why?
|
Vitamin A | 1 | 2014 | 610 | 0.090 |
Why?
|
Australasia | 1 | 2011 | 20 | 0.090 |
Why?
|
Observer Variation | 1 | 2017 | 2615 | 0.090 |
Why?
|
Ascorbic Acid | 1 | 2014 | 657 | 0.090 |
Why?
|
Family Planning Services | 1 | 2014 | 278 | 0.090 |
Why?
|
Health Promotion | 2 | 2017 | 2208 | 0.090 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2022 | 1480 | 0.090 |
Why?
|
Risk | 2 | 2013 | 9591 | 0.090 |
Why?
|
Gout | 1 | 2018 | 620 | 0.090 |
Why?
|
Sodium, Dietary | 1 | 2014 | 426 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2024 | 8041 | 0.090 |
Why?
|
Vitamin E | 1 | 2014 | 869 | 0.090 |
Why?
|
Eating | 1 | 2017 | 1539 | 0.090 |
Why?
|
Independent Living | 1 | 2014 | 585 | 0.090 |
Why?
|
Body Size | 1 | 2013 | 459 | 0.080 |
Why?
|
Forecasting | 2 | 2016 | 2936 | 0.080 |
Why?
|
Disability Evaluation | 1 | 2017 | 1820 | 0.080 |
Why?
|
Medically Uninsured | 1 | 2015 | 838 | 0.080 |
Why?
|
Calcium | 1 | 2023 | 5767 | 0.080 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2011 | 357 | 0.080 |
Why?
|
Qualitative Research | 1 | 2021 | 3138 | 0.080 |
Why?
|
Health Status Indicators | 1 | 2015 | 966 | 0.080 |
Why?
|
Nutritional Status | 1 | 2018 | 1620 | 0.080 |
Why?
|
Social Behavior | 1 | 2016 | 1146 | 0.080 |
Why?
|
Heart Diseases | 1 | 2022 | 2821 | 0.080 |
Why?
|
Schools | 2 | 2015 | 1492 | 0.080 |
Why?
|
Premature Birth | 1 | 2021 | 1829 | 0.080 |
Why?
|
Models, Biological | 2 | 2018 | 9443 | 0.080 |
Why?
|
Bariatric Surgery | 1 | 2019 | 997 | 0.080 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2015 | 838 | 0.080 |
Why?
|
Chile | 2 | 2022 | 258 | 0.080 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2015 | 1354 | 0.080 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 1217 | 0.080 |
Why?
|
Fasting | 2 | 2012 | 1606 | 0.080 |
Why?
|
Drug Therapy, Combination | 2 | 2022 | 6309 | 0.070 |
Why?
|
Veterans | 1 | 2022 | 2664 | 0.070 |
Why?
|
Hyperglycemia | 1 | 2016 | 1393 | 0.070 |
Why?
|
Natural Language Processing | 1 | 2017 | 1203 | 0.070 |
Why?
|
Ethiopia | 2 | 2021 | 485 | 0.070 |
Why?
|
Health Policy | 1 | 2020 | 2698 | 0.070 |
Why?
|
Odds Ratio | 2 | 2017 | 9649 | 0.070 |
Why?
|
Patient Compliance | 1 | 2018 | 2692 | 0.070 |
Why?
|
Mass Screening | 2 | 2020 | 5445 | 0.070 |
Why?
|
Diabetes Complications | 1 | 2014 | 1316 | 0.070 |
Why?
|
Particulate Matter | 1 | 2019 | 2624 | 0.070 |
Why?
|
Monte Carlo Method | 1 | 2013 | 1238 | 0.070 |
Why?
|
Rheumatic Diseases | 1 | 2014 | 622 | 0.070 |
Why?
|
North America | 1 | 2011 | 1285 | 0.070 |
Why?
|
Algorithms | 2 | 2018 | 14071 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2017 | 2243 | 0.070 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2008 | 212 | 0.070 |
Why?
|
Antirheumatic Agents | 1 | 2016 | 1365 | 0.070 |
Why?
|
Malaria, Falciparum | 1 | 2014 | 1075 | 0.070 |
Why?
|
Education | 2 | 2021 | 533 | 0.070 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2015 | 2187 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2023 | 22222 | 0.060 |
Why?
|
Telemedicine | 1 | 2023 | 3105 | 0.060 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2018 | 2531 | 0.060 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 1514 | 0.060 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2015 | 1188 | 0.060 |
Why?
|
Air Pollution | 1 | 2019 | 2380 | 0.060 |
Why?
|
Secondary Prevention | 1 | 2012 | 1472 | 0.060 |
Why?
|
Medical Records Systems, Computerized | 1 | 2011 | 1195 | 0.060 |
Why?
|
Survival Analysis | 1 | 2018 | 10070 | 0.060 |
Why?
|
Air Pollutants | 1 | 2019 | 2923 | 0.060 |
Why?
|
Pandemics | 2 | 2022 | 8701 | 0.060 |
Why?
|
Anthropometry | 3 | 2015 | 1338 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5189 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2016 | 4348 | 0.060 |
Why?
|
Computer Simulation | 1 | 2018 | 6255 | 0.060 |
Why?
|
Logistic Models | 2 | 2017 | 13266 | 0.060 |
Why?
|
Environmental Exposure | 1 | 2019 | 4543 | 0.060 |
Why?
|
Sodium | 2 | 2023 | 1591 | 0.060 |
Why?
|
Insurance Coverage | 1 | 2015 | 1944 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12057 | 0.050 |
Why?
|
Caregivers | 1 | 2016 | 2307 | 0.050 |
Why?
|
Arthritis, Rheumatoid | 2 | 2016 | 3733 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2018 | 4300 | 0.050 |
Why?
|
Regression Analysis | 1 | 2013 | 6321 | 0.050 |
Why?
|
Patient Readmission | 1 | 2017 | 3286 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2016 | 3229 | 0.050 |
Why?
|
Kidney | 1 | 2018 | 7066 | 0.050 |
Why?
|
Dinucleoside Phosphates | 1 | 2022 | 71 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6499 | 0.050 |
Why?
|
Biomedical Research | 1 | 2017 | 3458 | 0.050 |
Why?
|
Osteoarthritis, Knee | 1 | 2012 | 1248 | 0.050 |
Why?
|
Carbohydrates | 1 | 2024 | 386 | 0.050 |
Why?
|
Communication | 1 | 2015 | 3916 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2013 | 2531 | 0.050 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2024 | 263 | 0.050 |
Why?
|
Nepal | 1 | 2022 | 301 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2018 | 5369 | 0.040 |
Why?
|
Nutrition Policy | 2 | 2017 | 467 | 0.040 |
Why?
|
Australia | 1 | 2024 | 1258 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2014 | 2310 | 0.040 |
Why?
|
Medication Adherence | 1 | 2012 | 2190 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20125 | 0.040 |
Why?
|
Prognosis | 2 | 2019 | 29921 | 0.040 |
Why?
|
Nutritive Value | 1 | 2021 | 351 | 0.040 |
Why?
|
Health | 1 | 2021 | 397 | 0.040 |
Why?
|
Acculturation | 1 | 2020 | 178 | 0.040 |
Why?
|
Depression | 1 | 2018 | 8230 | 0.040 |
Why?
|
Language Development | 1 | 2019 | 183 | 0.040 |
Why?
|
Fishes | 1 | 2021 | 606 | 0.040 |
Why?
|
Probability | 1 | 2023 | 2475 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 1 | 2024 | 2587 | 0.040 |
Why?
|
Cholesterol, HDL | 1 | 2024 | 1811 | 0.030 |
Why?
|
Penicillamine | 1 | 2016 | 59 | 0.030 |
Why?
|
Sulfasalazine | 1 | 2016 | 85 | 0.030 |
Why?
|
Needs Assessment | 1 | 2022 | 1138 | 0.030 |
Why?
|
Philippines | 1 | 2015 | 95 | 0.030 |
Why?
|
Urban Population | 1 | 2024 | 2040 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2023 | 1272 | 0.030 |
Why?
|
Communication Disorders | 1 | 2015 | 50 | 0.030 |
Why?
|
Africa, Northern | 1 | 2015 | 85 | 0.030 |
Why?
|
Massachusetts | 2 | 2020 | 8871 | 0.030 |
Why?
|
Motor Skills Disorders | 1 | 2015 | 89 | 0.030 |
Why?
|
Leadership | 1 | 2024 | 1392 | 0.030 |
Why?
|
Minocycline | 1 | 2016 | 168 | 0.030 |
Why?
|
Azathioprine | 1 | 2016 | 350 | 0.030 |
Why?
|
Asthma | 1 | 2013 | 6270 | 0.030 |
Why?
|
Anti-HIV Agents | 2 | 2024 | 4559 | 0.030 |
Why?
|
Finland | 1 | 2015 | 608 | 0.030 |
Why?
|
Birth Order | 1 | 2014 | 93 | 0.030 |
Why?
|
Temperature | 1 | 2020 | 2226 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3202 | 0.030 |
Why?
|
Birth Weight | 1 | 2021 | 2122 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2014 | 508 | 0.030 |
Why?
|
Infant, Small for Gestational Age | 1 | 2015 | 469 | 0.030 |
Why?
|
Research Design | 2 | 2019 | 6208 | 0.030 |
Why?
|
Postnatal Care | 1 | 2014 | 274 | 0.020 |
Why?
|
Nutrition Assessment | 1 | 2015 | 738 | 0.020 |
Why?
|
Hydroxychloroquine | 1 | 2016 | 431 | 0.020 |
Why?
|
Cross-Cultural Comparison | 1 | 2015 | 634 | 0.020 |
Why?
|
Accidental Falls | 1 | 2020 | 1078 | 0.020 |
Why?
|
Fruit | 1 | 2017 | 1167 | 0.020 |
Why?
|
Vegetables | 1 | 2017 | 1200 | 0.020 |
Why?
|
Glucose | 1 | 2023 | 4335 | 0.020 |
Why?
|
Maternal Age | 1 | 2014 | 804 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2017 | 1668 | 0.020 |
Why?
|
Work | 1 | 2012 | 195 | 0.020 |
Why?
|
Family Characteristics | 1 | 2016 | 1001 | 0.020 |
Why?
|
Rural Population | 1 | 2021 | 2317 | 0.020 |
Why?
|
SEER Program | 1 | 2016 | 1446 | 0.020 |
Why?
|
Focus Groups | 1 | 2017 | 1459 | 0.020 |
Why?
|
Leisure Activities | 1 | 2012 | 310 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2023 | 3110 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2016 | 2228 | 0.020 |
Why?
|
China | 1 | 2016 | 2385 | 0.020 |
Why?
|
Methotrexate | 1 | 2016 | 1722 | 0.020 |
Why?
|
HIV | 1 | 2016 | 1585 | 0.020 |
Why?
|
Suicide | 1 | 2020 | 1604 | 0.020 |
Why?
|
Arthritis | 1 | 2014 | 677 | 0.020 |
Why?
|
Curriculum | 1 | 2022 | 3782 | 0.020 |
Why?
|
Obesity, Morbid | 1 | 2019 | 1292 | 0.020 |
Why?
|
Mothers | 1 | 2018 | 2208 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 4015 | 0.020 |
Why?
|
Motivation | 1 | 2017 | 2018 | 0.020 |
Why?
|
Prenatal Care | 1 | 2014 | 1159 | 0.020 |
Why?
|
Social Support | 1 | 2017 | 2192 | 0.020 |
Why?
|
Self Disclosure | 1 | 2008 | 248 | 0.020 |
Why?
|
Adolescent Behavior | 1 | 2015 | 1185 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2780 | 0.020 |
Why?
|
Motor Activity | 1 | 2016 | 2704 | 0.020 |
Why?
|
Health Care Reform | 1 | 2015 | 1259 | 0.020 |
Why?
|
Osteoarthritis | 1 | 2014 | 1051 | 0.020 |
Why?
|
Causality | 1 | 2012 | 1248 | 0.020 |
Why?
|
Systole | 1 | 2008 | 935 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2013 | 21056 | 0.020 |
Why?
|
World Health Organization | 1 | 2011 | 1328 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2022 | 81515 | 0.010 |
Why?
|
Walking | 1 | 2012 | 1198 | 0.010 |
Why?
|
Exercise Test | 1 | 2012 | 2180 | 0.010 |
Why?
|
Emotions | 1 | 2016 | 2763 | 0.010 |
Why?
|
Disabled Persons | 1 | 2013 | 1208 | 0.010 |
Why?
|
Mental Health | 1 | 2017 | 3272 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14652 | 0.010 |
Why?
|
Health Care Costs | 1 | 2015 | 3242 | 0.010 |
Why?
|
Pain Measurement | 1 | 2012 | 3561 | 0.010 |
Why?
|
Drug Utilization | 1 | 2008 | 1187 | 0.010 |
Why?
|
Cognition Disorders | 1 | 2015 | 3967 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2015 | 12437 | 0.010 |
Why?
|
Self Report | 1 | 2012 | 3771 | 0.010 |
Why?
|
Comorbidity | 1 | 2014 | 10563 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 8067 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9249 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13631 | 0.010 |
Why?
|
Health Behavior | 1 | 2008 | 2650 | 0.010 |
Why?
|
Animals | 1 | 2021 | 168759 | 0.010 |
Why?
|